Finding: 2 biomarkers for head and neck cancer can help predict radiation therapy resistance

International researchers led by Michigan's Beaumont Health System discovered two biomarkers that helped predict resistance to radiation therapy for patients with squamous cell cancer of the head and neck. They made their finding after screening thousands of genes in two different groups. The idea is that by knowing how a patient will respond to radiation therapy, if at all, physicians could pursue a more personalized treatment for that particular patient. Such a tool could also allow for better diagnosis of a patient and the calculation of that patient's odds of survival. Details are published in the European Journal of Cancer. Release

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.